Möchten Sie immer auf dem neuesten Stand bleiben?

Partnership Leverages Callan JMB's Federal Contract Experience, Cold Chain Infrastructure, and Strategic National Stockpile Relationships to Enable Immediate Deployment Readiness SPRING BRANCH, TX,...

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2...

Incannex earns global R&D recognition for advancing IHL-42X, a potential oral alternative for obstructive sleep apnea patients.

DUBAI, United Arab Emirates, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) has entered the later stages of its roadmap as development work continues ahead of its first protocol deployment....

MUNICH, Germany, Jan. 15, 2026 (GLOBE NEWSWIRE) --  HMNC Brain Health (“HMNC”), a clinical-stage precision psychiatry biopharma company pioneering the development of personalized therapies powered...

DUBAI, United Arab Emirates, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The DeFi market continues to produce new contenders as investors search for the next top crypto before the next major cycle. Many are...

Contributes 3 million ounces of production, enhancing grades and extending mine livesAll projects have an attractive NPV and IRR at a range of gold prices (This news release contains forward-looking...

DUBAI, United Arab Emirates, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a decentralized, non-custodial lending and borrowing protocol under development, has reported new presale...

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year...

Chicago, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The global central nervous system therapeutic market was valued at 129.38 billion in 2024 and is expected to reach US$ 235.87 billion by 2033, growing at a...